Works matching AU Si, Xiaoyan

Results: 63

Safety and Efficacy of the First Subcutaneous ICI, Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real‐World Study.

Published in:

Thoracic Cancer, 2025, v. 16, n. 12, p. 1, doi. 10.1111/1759-7714.70101

By:

Dou, Zixuan;
Wang, Li;
Rui, Meng;
Yang, Yulong;
Zhou, Yunzhi;
Zhang, JieLi;
Zhao, Qiuhong;
Wang, Mengzhao;
Wang, Hanping;
Zhang, Xiaotong;
Cui, Xiaoxia;
Si, Xiaoyan;
Zhang, Li

Publication type:

Article

Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 5545, doi. 10.2147/OTT.S204689

By:

Wang, Hanping;
Zhang, Li;
Shi, Xiaohua;
Zhang, Xiaotong;
Si, Xiaoyan

Publication type:

Article

Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 7513, doi. 10.2147/OTT.S174075

By:

Wang, Hanping;
Zhang, Li;
Si, Xiaoyan;
Zhang, Xiaotong;
Wang, Mengzhao

Publication type:

Article

Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03703-8

By:

Yadong Wang;
Zhicheng Huang;
Bowen Li;
Jianchao Xue;
Chao Guo;
Zhongxing Bing;
Zhibo Zheng;
Yang Song;
Yuan Xu;
Guanghua Huang;
Haochen Li;
Xiaoqing Yu;
Yankai Xia;
Ruirui Li;
Xiaoyan Si;
Li Zhang;
Ji Li;
Lan Song;
Yuanyuan Xiong;
Dejian Gu

Publication type:

Article

Synergistic effects of EP-1 and ivermectin mixture (iEP-1) to control rodents and their ectoparasites.

Published in:

Pest Management Science, 2023, v. 79, n. 2, p. 607, doi. 10.1002/ps.7226

By:

Ming Liu;
Dongsheng Ren;
Xinrong Wan;
Xiaona Shen;
Chaoyue Zhao;
Xingan;
Yujie Wang;
Fan Bu;
Wei Liu;
Zhongbing Zhang;
Yulong Gao;
Xiaoyan Si;
Defeng Bai;
Shuai Yuan;
Feng Zheng;
Xinru Wan;
Heping Fu;
Xiaodong Wu;
Aihua Zheng;
Qiyong Liu

Publication type:

Article

Clinical characteristics and management of immune checkpoint inhibitor‐related pneumonitis: A single‐institution retrospective study.

Published in:

Cancer Medicine, 2021, v. 10, n. 1, p. 188, doi. 10.1002/cam4.3600

By:

Wang, Hanping;
Zhao, Yanwei;
Zhang, Xiaotong;
Si, Xiaoyan;
Song, Peng;
Xiao, Yi;
Yang, Xu;
Song, Lan;
Shi, Juhong;
Zhao, Haitao;
Zhang, Li

Publication type:

Article

NLCIPS: Non-Small Cell Lung Cancer Immunotherapy Prognosis Score.

Published in:

Cancer Management & Research, 2020, v. 12, p. 5975, doi. 10.2147/CMAR.S257967

By:

Song, Peng;
Yang, Dongliang;
Cui, Xiaoxia;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li

Publication type:

Article

Pulmonary and Skeletal Infection of .

Published in:

2020

By:

Si, Xiaoyan;
Shi, Juhong

Publication type:

journal article

Pulmonary and Skeletal Infection of Mycobacterium kansasii.

Published in:

2020

By:

Xiaoyan Si;
Juhong Shi

Publication type:

Case Study

Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.

Published in:

BMC Immunology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12865-021-00430-y

By:

Xu, Feifan;
Zhang, Haiyun;
Si, Xiaoyan;
Chen, Junlin;
Chen, Yuhao;
Cui, Xiaopeng;
Qin, Yongwei

Publication type:

Article

Multiple infections of zoonotic pathogens in wild Brandt's voles (Lasiopodomys brandtii).

Published in:

Veterinary Medicine & Science, 2023, v. 9, n. 5, p. 2201, doi. 10.1002/vms3.1214

By:

Guo, Yongman;
Li, Zhengrun;
Dong, Shike;
Si, Xiaoyan;
Ta, Na;
Liang, Hanwei;
Xu, Lei

Publication type:

Article

Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study.

Published in:

Thoracic Cancer, 2023, v. 14, n. 21, p. 2038, doi. 10.1111/1759-7714.14987

By:

Si, Xiaoyan;
Zheng, Xueqing;
Tian, Xinlun;
Wang, Hanping;
Xu, Yan;
Zhao, Jing;
Chen, Minjiang;
Zhong, Wei;
Wang, Mengzhao;
Zhang, Li;
Zhang, Xiaotong

Publication type:

Article

Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 13, p. 1162, doi. 10.1111/1759-7714.14848

By:

Miao, Kang;
Zhang, Xiaotong;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Li

Publication type:

Article

The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 5, p. 497, doi. 10.1111/1759-7714.14772

By:

Jing Zhao;
Yang Wu;
Yuan Yue;
Minjiang Chen;
Yan Xu;
Xiangning Liu;
Xiaoyan Liu;
Xiaoxing Gao;
Hanping Wang;
Xiaoyan Si;
Wei Zhong;
Xiaotong Zhang;
Li Zhang;
Mengzhao Wang

Publication type:

Article

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 7, p. 1059, doi. 10.1111/1759-7714.14362

By:

Gao, Xiaoxing;
Pan, Ruili;
Chen, Minjiang;
Zhao, Jing;
Zhong, Wei;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li;
Xu, Yan;
Wang, Mengzhao

Publication type:

Article

Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.

Published in:

Thoracic Cancer, 2022, v. 13, n. 4, p. 539, doi. 10.1111/1759-7714.14289

By:

Jun Ni;
Xiaotong Zhang;
Hanping Wang;
Xiaoyan Si;
Yan Xu;
Jing Zhao;
Minjiang Chen;
Li Zhang;
Mengzhao Wang

Publication type:

Article

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2021, v. 12, n. 3, p. 357, doi. 10.1111/1759-7714.13757

By:

Si, Xiaoyan;
Pan, Ruili;
Ma, Shaohua;
Li, Lin;
Liang, Li;
Zhang, Ping;
Chu, Yuping;
Wang, Hanping;
Wang, Mengzhao;
Zhang, Xiaotong;
Zhang, Li

Publication type:

Article

Use of glucocorticoids in the management of immunotherapy‐related adverse effects.

Published in:

Thoracic Cancer, 2020, v. 11, n. 10, p. 3047, doi. 10.1111/1759-7714.13589

By:

Wang, Hanping;
Zhou, Jiaxin;
Guo, Xiaoxiao;
Li, Yue;
Duan, Lian;
SI, Xiaoyan;
Zhang, Li

Publication type:

Article

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events.

Published in:

Thoracic Cancer, 2020, v. 11, n. 8, p. 2077, doi. 10.1111/1759-7714.13553

By:

Song, Peng;
Wang, Hanping;
Si, Xiaoyan;
Guo, Xiaoxiao;
Li, Yue;
Zhou, Jiaixin;
Duan, Lian;
Zhang, Li;
Wang, Mengzhao

Publication type:

Article

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases.

Published in:

Thoracic Cancer, 2020, v. 11, n. 8, p. 2339, doi. 10.1111/1759-7714.13520

By:

Si, Xiaoyan;
Wang, Hanping;
Zhang, Xiaotong;
Wang, Mengzhao;
You, Yan;
Zhang, Li

Publication type:

Article

Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study.

Published in:

Thoracic Cancer, 2020, v. 11, n. 7, p. 1869, doi. 10.1111/1759-7714.13469

By:

Jun, Ni;
Hanping, Wang;
Xiaoyan, Si;
Yan, Xu;
Mengzhao, Wang;
Xiaotong, Zhang;
Li, Zhang

Publication type:

Article

Opportunistic infections complicating immunotherapy for non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 6, p. 1689, doi. 10.1111/1759-7714.13422

By:

Liu, Ziwei;
Liu, Tao;
Zhang, Xiaotong;
Si, Xiaoyan;
Wang, Hanping;
Zhang, Jingjia;
Huang, Hui;
Sun, Xuefeng;
Wang, Jinglan;
Wang, Mengzhao;
Zhang, Li

Publication type:

Article

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients.

Published in:

Thoracic Cancer, 2020, v. 11, n. 6, p. 1647, doi. 10.1111/1759-7714.13447

By:

Song, Peng;
Yang, Dongliang;
Wang, Hanping;
Cui, Xiaoxia;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li

Publication type:

Article

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients.

Published in:

Thoracic Cancer, 2020, v. 11, n. 6, p. 1621, doi. 10.1111/1759-7714.13442

By:

Song, Peng;
Yang, Dongliang;
Wang, Hanping;
Cui, Xiaoxia;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li

Publication type:

Article

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events.

Published in:

Thoracic Cancer, 2020, v. 11, n. 6, p. 1746, doi. 10.1111/1759-7714.13405

By:

Zheng, Ke;
Qiu, Wei;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li;
Li, Xuemei

Publication type:

Article

Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 5, p. 1216, doi. 10.1111/1759-7714.13376

By:

Song, Peng;
Zhang, Xiaotong;
Yang, Dongliang;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Li

Publication type:

Article

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 1099, doi. 10.1111/1759-7714.13347

By:

Duan, Lian;
Wang, Linjie;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Li, Yue;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Zhu, Huijuan

Publication type:

Article

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 829, doi. 10.1111/1759-7714.13338

By:

Li, Yue;
Kang, Xiaohui;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Qian, Jiaming

Publication type:

Article

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 810, doi. 10.1111/1759-7714.13327

By:

Liu, Xiaowei;
Wang, Zheng;
Zhao, Chan;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Li, Yue;
Wang, Mengzhao;
Zhang, Meifen

Publication type:

Article

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 805, doi. 10.1111/1759-7714.13313

By:

Lu, Minya;
Zhang, Li;
Li, Yue;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Si, Xiaoyan;
Xu, Yingchun

Publication type:

Article

Histologic transformation of lung cancer during pembrolizumab therapy: A case report.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 793, doi. 10.1111/1759-7714.13312

By:

Si, Xiaoyan;
You, Yan;
Zhang, Xiaotong;
Wang, Hanping;
Wang, Mengzhao;
Zhang, Li

Publication type:

Article

Management of immune checkpoint inhibitor‐related adverse events: A review of case reports.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 498, doi. 10.1111/1759-7714.13315

By:

Si, Xiaoyan;
Song, Peng;
Ni, Jun;
Di, Mingyi;
He, Chunxia;
Zhang, Li;
Liu, Xiaowei;
Li, Yue;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Yang, Xu;
Wang, Mengzhao

Publication type:

Article

Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 594, doi. 10.1111/1759-7714.13302

By:

Wang, Hanping;
Pan, Ruili;
Zhang, Xiaotong;
Si, Xiaoyan;
Wang, Mengzhao;
Zhang, Li

Publication type:

Article

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 799, doi. 10.1111/1759-7714.13281

By:

Zhuang, Junling;
Du, Jianhua;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Qiu, Wei;
Si, Xiaoyan;
Zhang, Li;
Li, Yue;
Liu, Xiaowei;
Wang, Hanping;
Zhou, Daobin

Publication type:

Article

Management of immune checkpoint inhibitor‐related dermatologic adverse events.

Published in:

Thoracic Cancer, 2020, v. 11, n. 2, p. 488, doi. 10.1111/1759-7714.13275

By:

Si, Xiaoyan;
He, Chunxia;
Zhang, Li;
Liu, Xiaowei;
Li, Yue;
Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Duan, Lian;
Wang, Mengzhao

Publication type:

Article

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity.

Published in:

Thoracic Cancer, 2020, v. 11, n. 2, p. 475, doi. 10.1111/1759-7714.13250

By:

Guo, Xiaoxiao;
Wang, Hanping;
Zhou, Jiaxin;
Li, Yue;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Fang, Ligang

Publication type:

Article

Management of immune checkpoint inhibitor‐related rheumatic adverse events.

Published in:

Thoracic Cancer, 2020, v. 11, n. 1, p. 198, doi. 10.1111/1759-7714.13249

By:

Zhou, Jiaxin;
Wang, Hanping;
Guo, Xiaoxiao;
Wang, Qian;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Li, Yue;
Zhang, Wen

Publication type:

Article

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis.

Published in:

Thoracic Cancer, 2020, v. 11, n. 1, p. 191, doi. 10.1111/1759-7714.13240

By:

Wang, Hanping;
Guo, Xiaoxiao;
Zhou, Jiaxin;
Li, Yue;
Duan, Lian;
Si, Xiaoyan;
Zhang, Li;
Liu, Xiaowei;
Wang, Mengzhao;
Shi, Juhong

Publication type:

Article

EGFR T790M detection in formalin‐fixed paraffin‐embedded tissues of patients with lung cancer using RNA‐based in situ hybridization: A preliminary feasibility study.

Published in:

Thoracic Cancer, 2019, v. 10, n. 10, p. 1936, doi. 10.1111/1759-7714.13169

By:

Wu, Shafei;
Shi, Xiaohua;
Si, Xiaoyan;
Liu, Yuanyuan;
Lu, Tao;
Zhang, Li;
Liang, Zhiyong;
Zeng, Xuan

Publication type:

Article

Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303.

Published in:

Thoracic Cancer, 2019, v. 10, n. 3, p. 551, doi. 10.1111/1759-7714.12977

By:

Si, Xiaoyan;
Zhang, Li;
Wang, Hanping;
Zhang, Xiaotong;
Wang, Mengzhao;
Han, Baohui;
Li, Kai;
Wang, Qiming;
Shi, Jianhua;
Wang, Zhehai;
Cheng, Ying;
Shi, Yuankai;
Chen, Weiqiang;
Wang, Xiuwen;
Luo, Yi;
Nan, Kejun;
Jin, Faguang

Publication type:

Article

Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma.

Published in:

Thoracic Cancer, 2018, v. 9, n. 8, p. 1056, doi. 10.1111/1759-7714.12789

By:

Si, Xiaoyan;
Wu, Shafei;
Wang, Hanping;
Zhang, Xiaotong;
Wang, Mengzhao;
Zeng, Xuan;
Zhang, Li

Publication type:

Article

Safety and efficacy of cetuximab combined with chemotherapy in Chinese patients with advanced non-small cell lung cancer.

Published in:

Thoracic Cancer, 2012, v. 3, n. 2, p. 188, doi. 10.1111/j.1759-7714.2011.00096.x

By:

Si, Xiaoyan;
Zhang, Li

Publication type:

Article

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920965849

By:

Si, Xiaoyan;
Wang, Jinwan;
Cheng, Ying;
Shi, Jianhua;
Cui, Liying;
Zhang, Helong;
Huang, Yunchao;
Liu, Wei;
Chen, Lei;
Zhu, Jiang;
Zhang, Shucai;
Li, Wei;
Sun, Yan;
Wang, Hanping;
Zhang, Xiaotong;
Wang, Mengzhao;
Yang, Lin;
Zhang, Li

Publication type:

Article

Real-Time Decision Support for Crew Assignment in Double-Ended Districts for U.S. Freight Railways.

Published in:

Transportation Science, 2016, v. 50, n. 4, p. 1337, doi. 10.1287/trsc.2016.0707

By:

Balakrishnan, Anantaram;
Kuo, April;
Si, Xiaoyan

Publication type:

Article

Chinese Expert Consensus on the Diagnosis and Treatment of Inflammatory Myofibroblastic Tumor.

Published in:

Thoracic Cancer, 2025, v. 16, n. 5, p. 1, doi. 10.1111/1759-7714.70027

By:

Si, Xiaoyan;
Wu, Shafei;
Feng, Rui'e;
Wang, Xuan;
Guan, Hui;
He, Jia;
Zeng, Xuan;
Song, Wei;
Li, Shanqing;
Hu, Ke;
Liang, Zhiyong;
Zhang, Fuquan;
Huo, Li;
Cheng, Xin;
Zhuo, Minglei;
Liu, Wei;
Liu, Yong;
Zhou, Xi;
Wang, Tao;
Zhang, Yuhui

Publication type:

Article

Clinicopathological Characteristics of Inflammatory Myofibroblastic Tumor: A Single Center Retrospective Cohort Study.

Published in:

Thoracic Cancer, 2025, v. 16, n. 1, p. 1, doi. 10.1111/1759-7714.15496

By:

Si, Xiaoyan;
Wu, Shafei;
Feng, Ruie;
Wang, Mengzhao;
Wang, Hanping;
Zhang, Xiaotong;
Zhang, Li;
Xu, Kaifeng

Publication type:

Article

Characterization of renal injury in non‐squamous non‐small cell lung cancer patients treated with pemetrexed: A single‐center retrospective study.

Published in:

Thoracic Cancer, 2024, v. 15, n. 35, p. 2474, doi. 10.1111/1759-7714.15470

By:

Wu, Yang;
Miao, Kang;
Chen, Minjiang;
Xu, Yan;
Zhong, Wei;
Wang, Hanping;
Si, Xiaoyan;
Zhang, Xiaotong;
Zhang, Li;
Zhao, Jing;
Wang, Mengzhao

Publication type:

Article

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.859938

By:

Miao, Kang;
Zhang, Xiaotong;
Wang, Hanping;
Si, Xiaoyan;
Ni, Jun;
Zhong, Wei;
Zhao, Jing;
Xu, Yan;
Chen, Minjiang;
Pan, Ruili;
Wang, Mengzhao;
Zhang, Li

Publication type:

Article

Single-cell profiling identifies IL1B<sup>hi</sup> macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46195-x

By:

Zhou, Ziyue;
Zhou, Xiaoxiang;
Jiang, Xu;
Yang, Bo;
Lu, Xin;
Fei, Yunyun;
Zhao, Lidan;
Chen, Hua;
Zhang, Li;
Si, Xiaoyan;
Liang, Naixin;
Wang, Yadong;
Yang, Dan;
Peng, Yezi;
Yang, Yiying;
Yao, Zhuoran;
He, Yangzhige;
Wu, Xunyao;
Zhang, Wen;
Wang, Min

Publication type:

Article

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non--Small Cell Lung Cancer.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.912180

By:

Kang Miao;
Xiaotong Zhang;
Hanping Wang;
Xiaoyan Si;
Jun Ni;
Wei Zhong;
Jing Zhao;
Yan Xu;
Minjiang Chen;
Ruili Pan;
Mengzhao Wang;
Li Zhang

Publication type:

Article